Allos Therapeutics (ALTH) Says EMA CHMP Recommends Against Approval for FOLOTYN as PTCL Treatment
Go back to Allos Therapeutics (ALTH) Says EMA CHMP Recommends Against Approval for FOLOTYN as PTCL Treatment| Allos Therapeutics (NASDAQ: ALTH) | Delayed: 1.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.84 | 52 Week High | $1.95 | |||
| Open | $166.29 | 52 Week Low | $1.25 | |||
| Day High | $1.84 | P/E | N/A | |||
| Day Low | $1.84 | EPS | $-0.35 | |||
| Volume | 288,441 | |||||
